P-EGS23 Efficacy of Percutaneous Cholecystostomy and Timing of Tube Removal: An Observational Study from a busy District General Hospital

Abstract Background Percutaneous cholecystostomy (PC) has traditionally been reserved for high-risk patients with cholecystitis who are unfit surgical intervention, or as a temporizing measure septic biliary to relieve sepsis and symptoms. However, there currently no guidelines regarding the timing of tube removal following PC. The aim this study is evaluate resolving inflammation patency ducts, its associated risks. Methods Patient notes imaging reports were retrospectively reviewed from those underwent percutaneous January 2015-Dec 2020. Data collected included demographic details, symptom presentation, requirement ITU admissions, details cholecystostomy, post-operative complications tube, outcomes PC, mortality rates within 30 days procedure. Patients graded by their severity according 2018 Tokyo Guidelines, these correlated morbidity 1 year Results There 55 females 65 males, mean age 75.2 years (range 45-96 years). Approximately 45% diabetic had comorbidities. On 54% (65/120) elevated inflammatory markers (WCC/CRP), 20% deranged liver function tests. Majority moderate severe acute cholecystitis, over 25% (31/120) presenting sepsis, 6 required admission intensive care. median time diagnosis was 8.5 1-64 days). Tube performed after 31 1-142 Morbidity rate observed be 8-10%, comprising such displacement, leakage around drain, bleeding abscesses. Only 18.3% (22/120) deemed fit further which 13 cholecystectomy thereafter. Unsurprisingly, 38% recurrent symptoms, 30% rate. Conclusions safe option in relief, crucial step de-escalating sepsis. suggests that variable, high morbidity. Consideration needs given shorten removal, minimise risks, if certain criteria met ensure safety efficacy.